首页 资讯 财经 公益 彩店 奇闻 速递 体育 提点 资讯 综合 企业 市场

首页
你现在的位置:

欧盟评估刺柏油和刺柏酊剂作为所有动物饲料添加剂的安全性和有效性

2023-04-21 11:08:18    来源:食品伙伴网    作者:


(资料图)

    2023年4月20日,据欧盟食品安全局(EFSA)消息,应欧盟委员会要求,欧盟动物饲料添加剂和产品(FEEDAP)研究小组就刺柏油和刺柏酊剂(juniper oil and juniper tincture)作为所有动物饲料添加剂的安全性和有效性发表科学意见。

经过评估,专家小组认为刺柏酊剂在动物饲料中最大建议使用量45%以下是安全的,对消费者和环境也是安全的。由于刺柏的果实及其制剂可以给食物调味,并且它们在饲料中的功能是相同的,因此认为没有必要证明其功效。部分原文报道如下:

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of juniper oil and juniper tincture obtained from the berries of Juniperus communis L., when used as sensory additives for all animal species. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that juniper oil is safe up to the maximum proposed use levels in complete feed of 5 mg/kg for laying hens, 15 mg/kg for veal calves (milk replacer) and cattle for fattening and 20 mg/kg for ornamental fish. For the other species, the calculated safe concentrations in complete feed were 4 mg/kg for chickens for fattening, 5 mg/kg for turkeys for fattening, 7 mg/kg for piglets, 8 mg/kg for pigs for fattening, 10 mg/kg for sows, dairy cows, 16 mg/kg for sheep, goats and horses, 6 mg/kg for rabbits, 17 mg/kg for salmonids, 18 mg/kg for dogs and 3 mg/kg for cats. These conclusions were extrapolated to other physiologically related species. For any other species, the additive was considered safe at 3 mg/kg complete feed. The FEEDAP Panel concluded that juniper tincture is safe up to the maximum proposed use level in feed of 45 mg/kg complete feed or water for drinking for all animal species. No concerns for consumers and the environment were identified following the use of the additives to the highest safe level in feed. The additives under assessment should be considered as irritants to skin and eyes, and as skin and respiratory sensitisers. Since the berries of J. communis and their preparations are recognised to flavour food and their function in feed would be the same as that in food, no further demonstration of efficacy was considered necessary.

编辑:qysb005

标签:

中国企业新闻网版权与免责声明:
1、中国企业新闻网所有内容的版权均属于作者或页面内声明的版权人。未经中国企业新闻网的书面许可, 任何其他个人或组织均不得以任何形式将河南企业网的各项资源转载、复制、编辑或发布使用于其他任何场合;不得把其中任何形式的资讯散发给其他方, 不可把这些信息在其他的服务器或文档中作镜像复制或保存;不得修改或再使用中国企业新闻网的任何资源。若有意转载本站信息资料, 必需取得中国企业新闻网书面授权。否则将追究其法律责任。
2、已经本网授权使用作品的,应在授权范围内使用,并注明“来源:中国企业新闻网”。违反上述声明者,本网将追究其相关法律责任。
3、凡本网注明“来源:XXX(非中国企业新闻网)”的作品,均转载自其它媒体,转载目的在于传递更多信息, 并不代表本网赞同其观点和对其真实性负责。本网转载其他媒体之稿件,意在为公众提供免费服务。如稿件版权单位或个人不想在本网发布, 可与本网联系,本网视情况可立即将其撤除。
图片欣赏
频道推荐
内容推荐
最近更新